Related Experiment Video
Updated: Jun 18, 2026
07:25
Lipid Supplementation for Longevity and Gene Transcriptional Analysis in Caenorhabditis elegans
Published on: December 9, 2022
Apolipoprotein E and its role in aging and survival
Francesca Bonomini1, Francesca Filippini, Tony Hayek
1Division of Human Anatomy, Department of Biomedical Sciences and Biotechnology, University of Brescia, Brescia, Italy.
Experimental Gerontology
|November 28, 2009
Summary
Apolipoprotein E (apoE) deficiency accelerates aging, causing organ damage and inflammation in mice. This highlights apoE
Area of Science:
- Gerontology and Aging Research
- Molecular Biology and Genetics
- Cardiovascular Disease Research
Background:
- Biological aging research has advanced significantly, with aging markers crucial for understanding age-related physiological changes.
- Apolipoprotein E (apoE) influences longevity, but its precise mechanisms remain unclear.
- ApoE-deficient mice are models for hypercholesterolemia and atherosclerosis, yet their aging characteristics are underexplored.
Purpose of the Study:
- To investigate the role of apolipoprotein E (apoE) in the aging process using a murine model.
- To assess the impact of apoE deficiency on organ morphology and biochemical markers of aging.
- To evaluate apoE's function in maintaining normal tissue structure and function during aging.
Main Methods:
- Utilized apolipoprotein E-deficient (E(0)) mice and control C57BL mice at ages 6, 12, and 20 weeks.
- Conducted morphological and biochemical analyses of kidney, liver, and heart tissues.
- Assessed markers of aging including fibrosis, pro-inflammatory cytokines (IL-6, iNOS), lipofuscin, and antioxidant enzymes (superoxide dismutase, catalase).
Main Results:
- E(0) mice exhibited age-dependent alterations: fibrosis, increased pro-inflammatory cytokines (IL-6, iNOS), lipofuscin accumulation, and decreased antioxidant enzymes (superoxide dismutase, catalase).
- These degenerative changes were observed in the kidney, liver, and heart of E(0) mice across all tested ages.
- Control C57BL mice did not display similar age-related degenerative findings at 6, 12, or 20 weeks of age.
Conclusions:
- Apolipoprotein E (apoE) plays a significant role in preventing age-associated organ damage and maintaining cellular health.
- ApoE deficiency accelerates aging phenotypes, indicating its importance in longevity and age-related diseases like inflammation and atherosclerosis.
- ApoE may be implicated in other pathologies, including cancer, rheumatoid arthritis, and macular degeneration.
Related Concept Videos
01:26Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
01:37Mitochondria
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
02:41Telomeres and Telomerase
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.